Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial

Patterson, J. K., Neuwahl, S., Kirsch, S., Moore, J. L., Tita, A. T. N., Carlo, W. A., Lokangaka, A., Tshefu, A., Mwenechanya, M., Chomba, E., Kavi, A., Metgud, M. C., Goudar, S. S., Derman, R. J., Shivkumar, P., Waikar, M., Patel, A., Hibberd, P. L., Nyongesa, P., … Bauserman, M. (2025). Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial. The Lancet Global Health, 13(4), e679–e688. https://doi.org/10.1016/s2214-109x(24)00517-5
Authors:
Jackie K Patterson
Simon Neuwahl
Sydney Kirsch
Janet L Moore
Alan T N Tita
Waldemar A Carlo
Adrien Lokangaka
Antoinette Tshefu
Musaku Mwenechanya
Elwyn Chomba
Avinash Kavi
Mrityunjay C Metgud
Shivaprasad S Goudar
Richard J Derman
Poonam Shivkumar
Manju Waikar
Archana Patel
Patricia L Hibberd
Paul Nyongesa
Fabian Esamai
Osa A Ekhaguere
Sherri Bucher
Saleem Jessani
Shiyam S Tikmani
Sarah Saleem
Blair J Wylie
Robert L Goldenberg
Sk Masum Billah
Ruth Lennox
Rashidul Haque
William A Petri
Manolo Mazariegos
Nancy F Krebs
Jennifer J Hemingway-Foday
Denise Babineau
Marion Koso-Thomas
Elizabeth M McClure
Melissa Bauserman
Affiliated Authors:
Blair J Wylie
Robert L Goldenberg
Columbia Affiliation:
Subjects:
Azithromycin (MeSH)
Cost-Benefit Analysis (MeSH)
Sepsis (MeSH)
Anti-Bacterial Agents (MeSH)
Developing Countries (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s2214-109x(24)00517-5
PMID:
40155105
DOI:
10.1016/s2214-109x(24)00517-5
Journal:
Lancet Global Health
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: